Clinical trial of external beam-radiotherapy combined with daily administration of low-dose cisplatin for supratentorial glioblastoma multiforme - A pilot study

Journal of Neuro-Oncology

Volumn 35, Issue 1, 1997, Pages 73-80

  Shinoda, Jun ^a   Sakai, Noboru ^a   Hara, Akira ^a   Ueda, Tatsuya ^a   Sakai, Hideki ^a   Nakatani, Kei ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

CDDP; External beam radiotherapy; Glioblastoma multiforme; Intraoperative radiotherapy

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; BRAIN NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030791352     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005816320920     Document Type: Article

References (29)

1. Feun LG, Stewart DJ, Maor M, Leavens M, Savaraj N, Burgess MA, Yung WA, Benjamin RS: A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas. J Neuro-Oncol 1: 109-113, 1983
2. Stewart DJ, O'Bryan RM, Al-Sarraf M, Costanzi JJ, Oishi N: Phase II study of cisplatin in recurrent astrocytomas in adults. A Southwest Oncology Group Study. J Neuro-Oncol 1: 145-147, 1983
3. Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B: Phase II evaluation of high-dose intra-venous cisplatin for treatment of adult malignant gliomas recurrent after chloroethyl-nitrosourea failure. J Neuro-Oncol 12: 187-191, 1992
4. Mortimer JE, Crowley J, Eyre H, Weiden P, Eltringham J, Stuckey WJ: Phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group Study. Cancer 69: 1220-1223, 1992
5. Hiesiger EM, Green SB, Shapiro WR, Burger PC, Selker RG, Mahaley MS Jr, Robertson JT, Hochberg FH, Young RF: Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A. J Neuro-Oncol 25: 143-154, 1995
6. Kiu M, Chang C, Cheng W, Lin T, Wong C, Tang SG, Leung W, Chen L, Ho Y,Ng K, Chen J, Yang T, Lai G: Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas. J Neuro-Oncol 25: 215-220, 1995
7. Douple EB, Richmond RC: Platinum complexes as radiosensitizers of hypoxic mammalian cells. Br J Cancer 37: 98-102, 1978
8. Chibber R, Stratford IJ, O'Neill P, Sheldon PW, Ahmed, Lee B: The interaction between radiation and complexes of cis-Pt (II) and Ph (II): studies at the molecular and cellular level. Int J Radiat Biol 48: 513-524, 1985
9. Begg AC, Van der Kolf PJ, Dewit L, Bartelink H: Radiosensitization by cisplatin of RIF1 tumor cells in vitro. Int J Radiat Biol 50: 871-884, 1986
10. Keizer HJ, Karim ABMF, Njo KH, Tierie AH, Snow GB, Vermorken JB, Pinedo HM: Feasibility study on daily administration of cis-diamminedichloroplatinum (II) in combination with radiotherapy. Radiother Oncol 1: 227-234, 1984
11. Fujita M, Masaki N, Murayama S, Matayoshi Y, Ikeda H, Shimizutani K, Inoue T, Kozuka T: Radiotherapy combined with daily administration of low dose cisplatin for head and neck cancer. Study on serum concentrations of cisplatin and acute complications. J Jpn Soc Ther Radiol Oncol 2: 255-262, 1990
12. Schaake-Koning C, Van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier J, van Zandwijk N, Bartelink H: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326: 524-530, 1992
13. Milano G, Troger V, Courdi A, Fantana X, Chauvel P, Lagrange JL: Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitizer. Cancer Chemother Pharmacol 27: 55-59, 1990
14. Yamada S, Takai Y, Nemoto K, Ogawa Y, Hoshi A, Mitsui H, Sakamoto K: Radiotherapy combined with daily low-dose cisplatin for esophageal carcinoma. A pilot study. Jpn J Cancer Chemother 21: 1689-1691, 1994
15. Begg AC, Behlken S, Bartelink H: The effect of cisplatin on the repair of radiation damage in RIF 1 mouse tumours in vitro. Radiother Oncol 15: 79-91, 1989
16. Trovo MG, Minatel E, Franchin G, Boccieri MG, Nascimben O, Bolzicco G, Pizzi G, Torretta A, Veronesi A, Gobitti C, Zanelli DJ, Monfardini S: Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24: 11-15, 1992
17. Bader JL, Glatstein E: Extent beam radiation therapy of gliomas. In: Kornblith PL, Walker MD (eds) Advances in Neuro-Oncology. Futura Publishing Company, Inc., Mount Kisco, New York 347-386, 1988
18. Barker FB II, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84: 442-448, 1996
19. Levin VA, Wara WM, Davis RL, Silver P, Pesser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB: NCOG protocol 6GL91: Response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme. Cancer Treat Rep 70: 739-743, 1986
20. Bashir R, Hochberg FH, Linggood RM, Hottleman K: Preirradiation internal carotid artery B CNU in treatment of glioblastoma multiforme. J Neurosurg 68: 917-919, 1988
21. Mbidde EK, Selby PJ, Perren TJ, Dearnalaey DP, Whitton A, Ashley S, Workman P, Bloom HJG, McElwain TJ: High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiatherapy for grade IV astrocytoma. Br J Cancer 58: 779-782, 1988
22. Kinsella TJ, Collins J, Rowland J, Klecker R, Wright D, Katz D, Steinberg SM: Pharmacology and Phase I/II study of continuous intravenous infusion of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6: 871-879, 1988
23. Roosen N, Kiwit JCS, Lins E, Schirmer M, Bock WJ: Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization grade IV gliomas of the brain. Cancer 64: 1984-1994, 1989
24. Marcial-Vega VA, Wharam MD, Leibel S, Clark A, Zweig R, Order SE: Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. Int J Radiat Oncol Biol Phys 16: 1419-1424, 1989
25. Greiner R, Blattmann H, Thum P, Bosiger P, Coray A, Kann R, Lahtinen T, Reinhardt H, von Essen CF, Zimmerman A: Anaplastic astrocytoma and glioblastoma: Pion irradiation with the dynamic conformation technique at the Swiss Institute for Nuclear Research (SIN). Radiother Oncol 17: 37-46, 1990
26. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 Final report. Int J Radiat Oncol Biol Phys 18: 321-324, 1990
27. Sakai N, Yamada H, Andoh T, Hirata T, Nishimura Y, Miwa Y, Shimuzu K, Yanagawa S: Intraoperative radiation therapy for malignant glioma. Neurol Med Chir (Tokyo) 31: 702-707, 1991
28. Tobias JS, Smith BJ, Blackman G, Finn G: Concurrent daily cisplatin and radiotherapy in locally advanced squamous carcinoma of the head-and-neck and bronchus. Radiother Oncol 9: 263-268, 1987
29. van Harskamp G, Boven E, Vermorken JB, van Deutekom H, Stam J, Njo KH, Karim AB, Tierie AH, Golding RP, Pinedo HM: Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 13: 1735-1738, 1987